Amedeo Columbano

Monserrato, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes.

Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes.

Journal: Cell death & disease

Published: May 14, 2025

Bridging dimensions: a comparative analysis of 2D and 3D in vitro models for hepatocellular carcinoma research.

Bridging dimensions: a comparative analysis of 2D and 3D in vitro models for hepatocellular carcinoma research.

Journal: Archives of toxicology

Published: May 13, 2025

Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes.

Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes.

Journal: Hepatology (Baltimore, Md.)

Published: June 21, 2023

Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis.

Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis.

Journal: Frontiers in oncology

Published: December 19, 2022

mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma.

mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: May 11, 2022

Deletion of Lactate Dehydrogenase-A Impairs Oncogene-Induced Mouse Hepatocellular Carcinoma Development.

Deletion of Lactate Dehydrogenase-A Impairs Oncogene-Induced Mouse Hepatocellular Carcinoma Development.

Journal: Cellular and molecular gastroenterology and hepatology

Published: November 04, 2021

TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD.

TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD.

Journal: International journal of molecular sciences

Published: October 22, 2021

Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia.

Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia.

Journal: Cell proliferation

Published: October 05, 2021

Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC.

Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC.

Journal: Cellular and molecular gastroenterology and hepatology

Published: June 18, 2021

Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma.

Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma.

Journal: Cancers

Published: September 27, 2020

Nrf2 in Neoplastic and Non-Neoplastic Liver Diseases.

Nrf2 in Neoplastic and Non-Neoplastic Liver Diseases.

Journal: Cancers

Published: September 09, 2020

Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis.

Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis.

Journal: Cancers

Published: June 17, 2020

Showing 1-12 of 57

Last Updated: 09/26/2026